H1 2025 saw stable SOM sales and strong growth in distribution, with net profit of ₪64.9M and robust cash flow. No impairment was recorded for Variscite, and the company maintained high liquidity and continued dividend payouts.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.